Malak Alharbi, PGY6 hematology oncology fellow at Roswell Park Comprehensive Cancer Center, shared an article on LinkedIn:
“Happy to share our recent publication on a case highlighting the diagnostic challenges at presentation and the therapeutic complexities of treating PRCA secondary to SMM.
We discuss the appropriate workup and explore daratumumab as a potential management option for these patients.
Thank you Dr Hillengass Jens for your support and mentorship!”
Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature.
Authors: Malak Alharbi, et al.
